The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Prepulse Inhibition Deficits and Perseverative Motor Patterns in Dopamine Transporter Knock-Out Mice: Differential Effects of D1 and D2 Receptor Antagonists
Open accessAbstract
Dopamine is known to regulate several behavioral phenomena, including sensorimotor gating and aspects of motor activity. The roles of dopamine D1 and D2 receptors in these behaviors have been documented in the rat literature, but few reports exist on their role in mice. We used dopamine transporter (DAT) (−/−) mice to examine the behavioral consequences of a chronically hyperdopaminergic state, challenging them with the preferential dopamine D2 receptor antagonist raclopride and D1 receptor antagonist SCH23390. At baseline, DAT (−/−) mice exhibited deficient sensorimotor gating as measured by prepulse inhibition (PPI) of the startle response, exhibited nonfocal perseverative patterns of locomotion, and were hyperactive in a novel environment. Pretreatment with raclopride significantly increased PPI in the DAT (−/−) mice, whereas SCH23390 had no significant effect. Blockade of D2 receptors did not affect the predominantly straight patterns of motor behavior produced by the DAT (−/−) mice, but antagonism of D1 receptors significantly attenuated the perseverative patterns, producing more of a meandering behavior seen in the DAT (+/+) control mice. Both D1 and D2 receptor antagonists decreased the hyperactivity seen in the DAT (−/−) mice. These findings support the role of the D2, but not the D1, receptor in the modulation of PPI in mice. Furthermore, D1 receptor activation appears to be the critical substrate for the expression of perseverative patterns of motor behavior, whereas both D1 and D2 receptors appear to regulate the amount of motor activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The DAT knockout mice phenotypes resemble amphetamine-like effects, and both hyperlocomotion and PPI deficits can be reversed with either D1 or D2 receptor antagonists [376], the atypical antipsychotics clozapine and quetiapine [377], various antidepressant drugs, and monoamine transporter inhibitors [378].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [376]
In the citing paper
“Mice lacking the DAT gene display markedly increased levels of DA in the mesolimbic system and striatum [373], that results in hyperlocomoter behaviors [373,374] and also deficits in PPI [375,376].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [376]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476
Self-citationGenetics of Mouse Behavior: Interactions with Laboratory Environment
Crabbe, J. C., Wahlsten, D., & Dudek, B. C. (1999) · Science · doi:10.1126/science.284.5420.1670 · Cited by 1,666
The more or less startling effects of weak prestimulation
Graham, F. K. (1975) · Psychophysiology · doi:10.1111/j.1469-8986.1975.tb01284.x · Cited by 1,119
Gating and Habituation of the Startle Reflex in Schizophrenic Patients
Braff, D. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820030038005 · Cited by 1,027
Hoffman, H. S., & Ison, J. R. (1980) · Psychological Review · doi:10.1037/0033-295x.87.2.175 · Cited by 780
Profound neuronal plasticity in response to inactivation of the dopamine transporter
Jones, S. R., Gainetdinov, R. R., Jaber, M., Giros, B., Wightman, R. M., & Caron, M. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.4029 · Cited by 712
Self-citationDopaminergic stimulation disrupts sensorimotor gating in the rat
Mansbach, R. S., Geyer, M. A., & BRAFF, D. L. (1988) · Psychopharmacology · doi:10.1007/bf00212846 · Cited by 606
Self-citationSensorimotor gating in boys with Tourette's syndrome and ADHD: Preliminary results
Castellanos, F. X., Fine, E. J., Kaysen, D. L., Marsh, W., Rapoport, J. L., & Hallett, M. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00101-8 · Cited by 395
A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder
Swerdlow, N. R., Benbow, C. H., Zisook, S., Geyer, M. A., & BRAFF, D. L. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90300-3 · Cited by 351
Self-citationCadenhead, K. S., Geyer, M. A., & BRAFF, D. L. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.12.1862 · Cited by 307
Self-citation
Research works printed but not linked: 2
- Paulus, 1997, Dopamine transporter (DAT) (+/−) and (−/−) mice exhibit graded changes in geometric patterns of locomotor behavior., Soc Neurosci Abstr, 23, 722.1
- Ralph, 1997, Prepulse inhibition deficits in dopamine transporter (DAT) knockout mice., Soc Neurosci Abstr, 23, 722.3
Cited by
Sorted by citations
Geyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100811 · Cited by 1,484
Self-citationDopamine: Functions, Signaling, and Association with Neurological Diseases
Klein, M. O., Battagello, D. S., Cardoso, A. R., Hauser, D. N., Bittencourt, J. C., & Correa, R. G. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0632-3 · Cited by 1,073
Beaulieu, J., Sotnikova, T. D., Yao, W., Kockeritz, L. K., Woodgett, J. R., Gainetdinov, R. R., & Caron, M. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307921101 · Cited by 815
Self-citationZweifel, L. S., Parker, J. G., Lobb, C. J., Rainwater, A., Wall, V. Z., Fadok, J. P., Darvas, M., Kim, M. J., Mizumori, S. J. Y., Paladini, C. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813415106 · Cited by 426
Monoamine Transporters: From Genes to Behavior
Gainetdinov, R. R., & Caron, M. G. (2003) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.050802.112309 · Cited by 398
Self-citationSchizophrenia-Relevant Behavioral Testing in Rodent Models: A Uniquely Human Disorder?
Powell, C. M., & Miyakawa, T. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.008 · Cited by 381
van den Buuse, M. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp132 · Cited by 352
Prickaerts, J., Moechars, D., Cryns, K., Lenaerts, I., van Craenendonck, H., Goris, I., Daneels, G., Bouwknecht, J. A., & Steckler, T. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5216-05.2006 · Cited by 341
Animal Foraging and the Evolution of Goal‐Directed Cognition
Hills, T. T. (2006) · Cognitive Science · doi:10.1207/s15516709cog0000_50 · Cited by 345
Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299
Mouse genetic models for prepulse inhibition: an early review
Geyer, M. A., McIlwain, K. L., & Paylor, R. E. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001159 · Cited by 289
Self-citationSchizophrenia: from phenomenology to neurobiology
Wong, A. H. C., & Tol, H. H. M. V. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00035-6 · Cited by 292
Prepulse inhibition and genetic mouse models of schizophrenia
Powell, S. B., Zhou, X., & Geyer, M. A. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.04.021 · Cited by 218
Self-citationAberrant responses in social interaction of dopamine transporter knockout mice
Rodriguiz, R. M., Chu, R., Caron, M. G., & Wetsel, W. C. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00187-6 · Cited by 227
Self-citationVuillermot, S., Weber, L., Feldon, J., & Meyer, U. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5408-09.2010 · Cited by 228
Haenisch, B., & Bönisch, H. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.12.002 · Cited by 215
Leo, D., Sukhanov, I., Zoratto, F., Illiano, P., Caffino, L., Sanna, F., Messa, G., Emanuele, M., Esposito, A., Dorofeikova, M., et al. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1931-17.2018 · Cited by 209
Self-citationGenetic animal models: focus on schizophrenia
Gainetdinov, R. R., Mohn, A. R., & Caron, M. G. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01886-5 · Cited by 201
Self-citationDeletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice
Ortega-Álvaro, A., Aracil-Fernández, A., García‐Gutiérrez, M. S., Navarrete, F., & Manzanares, J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.34 · Cited by 190
The family of sensorimotor gating disorders: Comorbidities or diagnostic overlaps?
Geyer, M. A. (2006) · Neurotoxicity Research · doi:10.1007/bf03033358 · Cited by 159
Self-citationGlutamatergic modulation of hyperactivity in mice lacking the dopamine transporter
Gainetdinov, R. R., Mohn, A. R., Bohn, L., & Caron, M. G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191353298 · Cited by 168
Self-citationRegulation of monoamine transporters: Role of transporter phosphorylation
Ramamoorthy, S., Shippenberg, T. S., & Jayanthi, L. D. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.09.009 · Cited by 151
Novelty Seeking and Stereotypic Activation of Behavior in Mice with Disruption of the Dat1 Gene
Pogorelov, V. M., Rodriguiz, R. M., Insco, M. L., Caron, M. G., & Wetsel, W. C. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300724 · Cited by 151
Self-citationKarasinska, J. M., Rinninger, F., Lütjohann, D., Ruddle, P., Franciosi, S., Kruit, J. K., Singaraja, R. R., Hirsch-Reinshagen, V., Fan, J., Brunham, L. R., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4741-08.2009 · Cited by 133
Mackeprang, T., Kristiansen, K. T., & Glenthoj, B. Y. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01409-9 · Cited by 144
Unger, E. L., Eve, D. J., Perez, X. A., Reichenbach, D. K., Xu, Y., Lee, M. K., & Andrews, A. M. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.005 · Cited by 137
Tanda, K., Nishi, A., Matsuo, N., Nakanishi, K., Yamasaki, N., Sugimoto, T., Toyama, K., Takao, K., & Miyakawa, T. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-19 · Cited by 136
Predictive animal models of mania: hits, misses and future directions
Young, J. W., Henry, B. L., & Geyer, M. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01318.x · Cited by 136
Self-citationMonoamine transporter pharmacology and mutant mice
Gainetdinov, R. R., Sotnikova, T. D., & Caron, M. G. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02044-8 · Cited by 126
Self-citationGreenwood, T. A., Swerdlow, N. R., Gur, R. E., Cadenhead, K. S., Calkins, M. E., Dobie, D. J., Freedman, R., Green, M. F., Gur, R. C., Lazzeroni, L. C., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12020186 · Cited by 124
Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease
Lohr, K. M., Masoud, S. T., Salahpour, A., & Miller, G. W. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13357 · Cited by 127
Genetic Models of Sensorimotor Gating: Relevance to Neuropsychiatric Disorders
Powell, S. B., Weber, M., & Geyer, M. A. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_195 · Cited by 127
Self-citationSpeca, D. J., Ogata, G., Mandikian, D., Bishop, H. I., Wiler, S. W., Eum, K. S., Wenzel, H. J., Doisy, E. T., Matt, L., Campi, K. L., et al. (2014) · Genes Brain & Behavior · doi:10.1111/gbb.12120 · Cited by 122
Young, J. W., Minassian, A., Paulus, M. P., Geyer, M. A., & Perry, W. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.05.009 · Cited by 122
Self-citationMazei‐Robison, M. S., Couch, R. S., Shelton, R. C., Stein, M. A., & Blakely, R. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.08.003 · Cited by 116
Ralph, R. J., Paulus, M. P., Zhuang, X., Hen, R., & Geyer, M. A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01489-0 · Cited by 119
Self-citationSTOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating
Fradley, R. L., O’Meara, G. F., Newman, R. J., Andrieux, A., Job, D., & Reynolds, D. S. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.05.012 · Cited by 127
Acoustic startle and prepulse inhibition in 40 inbred strains of mice.
Willott, J. F., Tanner, L. H., O'steen, J. R., Johnson, K. R., Bogue, M. A., & Gagnon, L. H. (2003) · Behavioral Neuroscience · doi:10.1037/0735-7044.117.4.716 · Cited by 115
Ralph, R. J., Masten, V. L., Otero-Corchón, V., Low, M. J., & Geyer, M. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09604.2002 · Cited by 110
Self-citationAnimal models for bipolar disorder: from bedside to the cage
Beyer, D. K. E., & Freund, N. (2017) · International Journal of Bipolar Disorders · doi:10.1186/s40345-017-0104-6 · Cited by 113
Genetic Mouse Models of Schizophrenia: From Hypothesis-Based To Susceptibility Gene-Based Models
Chen, J., Lipska, B. K., & Weinberger, D. R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.024 · Cited by 108
Parallel Loss of Hippocampal LTD and Cognitive Flexibility in a Genetic Model of Hyperdopaminergia
Morice, É., Billard, J., Denis, C., Mathieu, F., Betancur, C., Epelbaum, J., Giros, B., & Nosten‐Bertrand, M. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301354 · Cited by 113
Kawahara, Y., Grimberg, A., Teegarden, S., Mombereau, C., Liu, S., Bale, T. L., Blendy, J. A., & Nishikura, K. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3896-08.2008 · Cited by 105
The catecholaminergic–cholinergic balance hypothesis of bipolar disorder revisited
van Enkhuizen, J., Janowsky, D. S., Olivier, B., Minassian, A., Perry, W., Young, J. W., & Geyer, M. A. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.05.063 · Cited by 111
Self-citationDopamine D1 Rather than D2 Receptor Agonists Disrupt Prepulse Inhibition of Startle in Mice
Ralph-Williams, R. J., Lehmann-Masten, V., & Geyer, M. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300017 · Cited by 105
Self-citationBarr, A. M., Lehmann-Masten, V., Paulus, M., Gainetdinov, R. R., Caron, M. G., & Geyer, M. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300343 · Cited by 103
Self-citationRalph, R. J., & Caine, S. B. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.074468 · Cited by 103
Self-citationNegative affective states and cognitive impairments in nicotine dependence
Hall, F. S., Der‐Avakian, A., Gould, T. J., Markou, A., Shoaib, M. C., & Young, J. W. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.06.004 · Cited by 110
Risbrough, V. B., Masten, V. L., Caldwell, S., Paulus, M. P., Low, M. J., & Geyer, M. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301161 · Cited by 102
Self-citationDisruption of prepulse inhibition in mice lacking mGluR1
Brody, S. A., Conquet, F., & Geyer, M. A. (2003) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2003.03073.x · Cited by 97
Self-citationSiuta, M., Robertson, S. D., Kocalis, H. E., Saunders, C., Gresch, P. J., Khatri, V., Shiota, C., Kennedy, J. P., Lindsley, C. W., Daws, L. C., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000393 · Cited by 98
Urs, N. M., Snyder, J. C., Jacobsen, J. P. R., Peterson, S. M., & Caron, M. G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215489109 · Cited by 92
Self-citationFernagut, P., Chalon, S., Diguet, E., Guilloteau, D., Tison, F., & Jaber, M. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00778-9 · Cited by 91
Social Deficits and Perseverative Behaviors, but not Overt Aggression, in MAO-A Hypomorphic Mice
Bortolato, M., Chen, K., Godar, S. C., Chen, G., Wu, W., Rebrin, I., Farrell, M. R., Scott, A. L., Wellman, C. L., & Shih, J. C. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.157 · Cited by 90
Tanaka, K., Shintani, N., Hashimoto, H., Kawagishi, N., Ago, Y., Matsuda, T., Hashimoto, R., Kunugi, H., Yamamoto, A., Kawaguchi, C., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4376-05.2006 · Cited by 85
Kalueff, A. V., Jensen, C. L., & Murphy, D. L. (2007) · Brain Research · doi:10.1016/j.brainres.2007.07.009 · Cited by 85
Dopamine transporter mutant animals: a translational perspective
Efimova, E. V., Gainetdinov, R. R., Budygin, E. A., & Sotnikova, T. D. (2016) · Journal of Neurogenetics · doi:10.3109/01677063.2016.1144751 · Cited by 86
Gap junctions in developing neocortex: a review
Montoro, R. J., & Yuste, R. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.06.009 · Cited by 83
Huotari, M., Sántha, M., Lucas, L., Karayiorgou, M., Gogos, J. A., & Männistö, P. T. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.043042 · Cited by 81
Impaired cliff avoidance reaction in dopamine transporter knockout mice
Yamashita, M., Sakakibara, Y., Hall, F. S., Numachi, Y., Yoshida, S., Kobayashi, H., Uchiumi, O., Uhl, G. R., Kasahara, Y., & Sora, I. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3009-9 · Cited by 83
Yamashita, M., Fukushima, S., Shen, H.-W., Hall, F. S., Uhl, G. R., Numachi, Y., Kobayashi, H., & Sora, I. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301009 · Cited by 77
Meck, W. H., Cheng, R., MacDonald, C. J., Gainetdinov, R. R., Caron, M. G., & Çevik, M. Ö. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.042 · Cited by 77
Self-citationXu, T., Sotnikova, T. D., Liang, C., Zhang, J., Jung, J. U., Spealman, R. D., Gainetdinov, R. R., & Yao, W. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0974-09.2009 · Cited by 80
Dopamine transporter mutant mice in experimental neuropharmacology
Gainetdinov, R. R. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0216-0 · Cited by 79
Xu, R., Hranilović, D., Fetsko, L. A., Bućan, M., & Wang, Y. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001145 · Cited by 75
Dopamine transporter‐dependent and ‐independent actions of trace amine β‐phenylethylamine
Sotnikova, T. D., Budygin, E. A., Jones, S. R., Dykstra, L., Caron, M. G., & Gainetdinov, R. R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02721.x · Cited by 74
Self-citationPark, S. M., Chen, M., Schmerberg, C. M., Dulman, R. S., Rodriguiz, R. M., Caron, M. G., Jin, J. J., & Wetsel, W. C. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.196 · Cited by 74
Self-citationHall, F. S., Drgonová, J., Jain, S., & Uhl, G. R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.07.006 · Cited by 76
Effects of sex and estrous cycle on modulation of the acoustic startle response in mice
Plappert, C. F., RODENBUCHER, A., & Pilz, P. K. D. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.02.004 · Cited by 72
Klejbor, I., Myers, J. M., Hausknecht, K., Corso, T. D., Gambino, A. S., Moryś, J., Maher, P., Hard, R., Richards, J. C., Stachowiak, E., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03754.x · Cited by 76
Effect of antipsychotic treatment on the prepulse inhibition deficit of mGluR5 knockout mice
Brody, S. A., Conquet, F., & Geyer, M. A. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1635-3 · Cited by 68
Self-citationKalinichev, M., & Dawson, L. A. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001495 · Cited by 69
Mereu, M., Contarini, G., Buonaguro, E. F., Latte, G., Managò, F., Iasevoli, F., de Bartolomeis, A., & Papaleo, F. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.037 · Cited by 69
Cross-species assessments of motor and exploratory behavior related to bipolar disorder
Henry, B. L., Minassian, A., Young, J. W., Paulus, M. P., Geyer, M. A., & Perry, W. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.04.002 · Cited by 65
Self-citationPregnenolone Rescues Schizophrenia-Like Behavior in Dopamine Transporter Knockout Mice
Wong, P., Chang, C. C. R., Marx, C. E., Caron, M. G., Wetsel, W. C., & Zhang, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051455 · Cited by 65
Self-citationMouse Models of Autism: Testing Hypotheses About Molecular Mechanisms
Roullet, F., & Crawley, J. N. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_113 · Cited by 67
Zuloaga, D., Poort, J. E., Jordan, C. L., & Breedlove, S. (2011) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.07.008 · Cited by 56
Kuroiwa, M., Snyder, G. L., Shuto, T., Fukuda, A., Yanagawa, Y., Benavides, D. R., Nairn, A. C., Bibb, J. A., Greengard, P., & Nishi, A. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2436-8 · Cited by 64
Skirzewski, M., Karavanova, I. D., Shamir, A., Erben, L., García‐Olivares, J., Shin, J. H., Vullhorst, D., Alvarez, V. A., Amara, S., & Buonanno, A. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.132 · Cited by 62
Altered Neurocircuitry in the Dopamine Transporter Knockout Mouse Brain
Zhang, X., Bearer, E. L., Boulat, B., Hall, F. S., Uhl, G. R., & Jacobs, R. E. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011506 · Cited by 63
Hagino, Y., Takamatsu, Y., Yamamoto, H., Iwamura, T., Murphy, D. L., Uhl, G. R., Sora, I., & Ikeda, K. (2011) · Current Neuropharmacology · doi:10.2174/157015911795017254 · Cited by 60
Powell, S. B., Young, J. W., Ong, J. C., Caron, M. G., & Geyer, M. A. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830dc110 · Cited by 57
Self-citationWeiss, S., Nosten‐Bertrand, M., McIntosh, J. M., Giros, B., & Martres, M. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301385 · Cited by 58
Animal models of tic disorders: A translational perspective
Godar, S. C., Mosher, L. J., Giovanni, G. D., & Bortolato, M. (2014) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2014.09.008 · Cited by 55
Brain hyperserotonemia causes autism-relevant social deficits in mice
Tanaka, M., Sato, A., Kasai, S., Hagino, Y., Kotajima‐Murakami, H., Kashii, H., Takamatsu, Y., Nishito, Y., Inagaki, M., Mizuguchi, M., et al. (2018) · Molecular Autism · doi:10.1186/s13229-018-0243-3 · Cited by 63
Stachowiak, M. K., Kucinski, A. J., Curl, R., Syposs, C., Yang, Y., Narla, S. T., Terranova, C. J., Prokop, D., Klejbor, I., Bencherif, M., et al. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.11.004 · Cited by 54
Lauer, A. M., Behrens, D., & Klump, G. M. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.03.009 · Cited by 53
Mice lacking synapsin III show abnormalities in explicit memory and conditioned fear
Porton, B., Rodriguiz, R. M., Phillips, L. E., Gilbert, J. W., Feng, J., Greengard, P., Kao, H., & Wetsel, W. C. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00555.x · Cited by 51
Pre-attentive processing and schizophrenia: animal studies
Ellenbroek, B. A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1684-7 · Cited by 50
Kaga, Y., Shoemaker, W. J., Furusho, M., Bryant, M., Rosenbluth, J., Pfeiffer, S. E., Oh, L. Y. S., Rasband, M. N., Lappe-Siefke, C., Yu, K., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3573-06.2006 · Cited by 50
Hsieh, P. C., Yeh, T. L., Lee, I. H., Huang, H. C., Chen, P. S., Yang, Y. K., Chiu, N.-T., Lu, R. B., & Liao, M. (2010) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.090007 · Cited by 47
Fox, M. A., Panessiti, M., Hall, F. S., Uhl, G. R., & Murphy, D. L. (2013) · Psychopharmacology · doi:10.1007/s00213-013-2988-x · Cited by 49
Khoja, S., Shah, V. D., Garcia, D., Asatryan, L., Jakowec, M. W., & Davies, D. L. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13734 · Cited by 49
Implication of Neuronal Versus Microglial P2X4 Receptors in Central Nervous System Disorders
Duveau, A., Bertin, É., & Boué‐Grabot, É. (2020) · Neuroscience Bulletin · doi:10.1007/s12264-020-00570-y · Cited by 48
Wong, P., Sze, Y., Chang, C. C. R., Lee, J., & Zhang, X. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.21 · Cited by 45
Dallaire, J. A., Meagher, R. K., Díez‐León, M., Garner, J. P., & Mason, G. J. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.03.061 · Cited by 45
Dopamine and the Development of Executive Dysfunction in Autism Spectrum Disorders
Kriete, T. E., & Noelle, D. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121605 · Cited by 49
Boulay, D., Bergis, O. E., Avenet, P., & Griebel, G. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.144 · Cited by 45
Animal models to guide clinical drug development in ADHD: lost in translation?
Wickens, J. R., Hyland, B. I., & Tripp, G. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01412.x · Cited by 45
Amphetamine increases activity but not exploration in humans and mice
Minassian, A., Young, J. W., Cope, Z. A., Henry, B. L., Geyer, M. A., & Perry, W. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4098-4 · Cited by 44
Self-citation
Metadata
- Authors
- Ralph, R. J., Paulus, M. P., Fumagalli, F., Caron, M. G., & Geyer, M. A.
- Affiliations
- University of California San Diego (US)
- University of Milan (IT)
- Howard Hughes Medical Institute (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2001-01-01
- Volume
- 21
- Issue
- 1
- Pages
- 305-313
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6762423
- OpenAlex
- W2133067994
- Cited by
- 271
- References
- 31
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 4 · 2023: 12 · 2022: 9 · 2021: 4 · 2020: 7 · 2019: 7 · 2018: 6 · 2017: 8 · 2016: 13 · 2015: 12 · 2014: 15 · 2013: 12 · 2012: 11
- FWCI
- 5.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- U.S. Department of Veterans Affairs
- National Institutes of Health (5r01da011277-03)
- National Institute of Mental Health (F31-MH-12806, MH42228, R37MH042228, R01MH042228, R01MH061326)
- National Institute on Drug Abuse (DA 02925, R01DA002925, DA11277)
- NIH Clinical Center
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- prepulse inhibition, sensorimotor gating, dopamine transporter knockout mice, dopamine D1 receptor, dopamine D2 receptor, dopamine D1 receptor antagonist, dopamine D2 receptor antagonists, raclopride, SCH 23390, locomotor hyperactivity, hyperdopaminergic state
- MeSH terms
- Animals, Behavior, Animal, Benzazepines, Carrier Proteins, Female, Heterozygote, Homozygote, Hyperkinesis, Injections, Intraperitoneal, Injections, Subcutaneous, Male, Membrane Glycoproteins, Motor Activity, Movement Disorders, Nerve Tissue Proteins, Neural Inhibition, Sex Factors, Reflex, Startle, Receptors, Dopamine D1, Receptors, Dopamine D2, Mice, Knockout, Dopamine Antagonists, Raclopride, Membrane Transport Proteins, Dopamine Plasma Membrane Transport Proteins, Mice, Dopamine D2 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
